Gagnon Robert E.

Director | Chief Financial Officer

3 companies

Strong

Trades Analyzed

12M Win Rate

63.0%

Avg 3M Return

-5.7%

Avg 12M Return

+3.9%

Gagnon Robert E. is a Chief Financial Officer at IRD with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $2.0M based on current market prices.

Holdings by Company

IRDSep 10, 2025

Current Shares200.0K

Value$998.0K

Net Activity0

Bought: 0Sold: 0

HBIOJul 16, 2025

Current Shares110.0K

Value$758.5K

Net Activity-425,547

Bought: 30.5KSold: 456.0K

VSTMDec 16, 2025

Current Shares41.7K

Value$203.8K

Net Activity-87,434

Bought: 0Sold: 87.4K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 3, 2022	VSTM Verastem, Inc.	Chief Financial Officer	Sell	19,612	$2.05	$40,204.60	-3.4%	-27.1%	-80.0%
Dec 20, 2021	VSTM Verastem, Inc.	Chief Financial Officer	Sell	5,497	$2.27	$12,478.19	-0.9%	-44.3%	-83.7%
Aug 29, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sell	8,889	$5.77	$51,289.53	-2.7%	-	-
Aug 7, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sale+OE	100,015	$6.08	$608,091.20	-22.3%	-	-
Jul 27, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sale+OE	62,514	$5.54	$346,327.56	-14.7%	-	-
Jul 24, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sell	5,570	$5.25	$29,242.50	-1.5%	-	-
Jul 23, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sell	2,565	$5.25	$13,466.25	-0.3%	-	-
Jul 13, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sale+OE	10,207	$5.25	$53,586.75	-1.3%	-	-
Jul 11, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sale+OE	169,200	$5.26	$889,527.00	-12.3%	-	-
Mar 7, 2018	HBIO Harvard Bioscience Inc	Chief Financial Officer	Sell	97,087	$4.62	$448,541.94	-21.3%	-	-